Novo Nordisk CEO to step down as Wegovy maker faces growing competition
found
The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth transition to new leadership."
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Fruergaard Jørgensen
since
auto-detected in 27 stories
6 months ago
9 months ago
Denmark wanted advice on handling Trump. It turned to Ozempic’s boss.
found
a story from Politico EU ✅ › Politico EU
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — reluctantly — into the limelight.
page 1 of 1